Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fermentum Biotecnología is a Mexican biotechnology company specialized in the research, development, and commercialization of probiotic-based health solutions. The company focuses on the therapeutic potential of specific bacterial strains, most notably Lactobacillus fermentum, to address gastrointestinal health and immune system modulation. Fermentum's business model integrates scientific research with the production of functional foods and supplements, positioning itself as a leader in the Mexican microbiome market. Their flagship products are designed to restore gut flora balance and provide adjunctive support for various inflammatory and digestive conditions. The company maintains a strong focus on clinical validation and high-quality manufacturing standards for live biotherapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fermentum.